Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 4028-4032

  Heijligenberg, R ^a   Sauerwein, H P ^a   Brabant, G ^b   Endert, E ^a   Hommes, M J ^a   Romijn, J A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BODY CONSTITUTION; CIRCADIAN RHYTHM; HIV INFECTIONS; HIV WASTING SYNDROME; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029847997     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.4028     Document Type: Article

References (38)

1. Hoover DR, Saah AJ, Bacellar H, et al. 1993 Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N Engl J Med. 392:1922-1926.
2. Nahlen BL, Chu SY, Nwanyanwu OC, Berkelman RL, Martinez SA, Rullan JV. 1993 HIV wasting syndrome in the USA. AIDS. 7:183-188.
3. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. 1992 Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr. 55:455-460.
4. Grunfeld C, Feingold KR. 1993 Body weight as essential data in the management of patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr. 58:317-318.
5. Kotler DP, Tierney AR, Brenner SK, Couture S, Wang J, Pierson Jr RN. 1990 Preservation of short-term energy balance in clinically stable patients with AIDS. Am J Clin Nutr. 51:7-13.
6. Schwenk A, Burger B, Wessel D, et al. 1993 Clinical risk factors for malnutrition in HIV-1-infected patients. AIDS. 7:1213-1219.
7. Macallan DC, Noble C, Baldwin C, Foskett M, Mcmanus T, Griffin GE. 1993 Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr. 58:417-424.
8. Suttmann U, Ockenga J, Hoogestraat L, et al. 1993 Resting energy expenditure and weight loss in human immunodeficiency virus infected patients. Metabolism. 42:1173-1179.
9. Kotler DP, Wang J, Pierson RN. 1985 Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 42:1255-1265.
10. Grunfeld C, Feingold KR. 1992 Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 327:329-337.
11. Jorgensen JOL, Moller J, Alberti KGMM, et al. 1993 Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab. 77:1589-1596.
12. Franco Salomon R. 1989 The effets of treatment with rGH on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 12:1797-1803.
13. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. 1991 Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg. 126:38-43.
14. Krentz AJ, Koster FT, Crist DM, et al. 1993 Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquired Immune Defic Syndr. 6:245-251.
15. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. 1993 Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab. 77:956-962.
16. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. 1994 Anabolic effects of recombinant insulin-like growth factor I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 78:404-410.
17. Veldhuis JD, Jonson ML. 1986 Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E484-E493.
18. Prank K, Brabant G. 1994 Estimating thyrotropin secretory activity by a deconvolution procedure. In: Methods in neurosciences, vol 20. New York: Academic Press; vol 20:377-390.
19. Brabant G, Prank K, Ranft U, et al. 1990 Circadian and pulsatile TSH secretion under physiological and pathophysiological conditions. Horm Metab Res (Suppl Ser). 23:12-17.
20. Riedel M, Gunther T, von zur Muhlen A, Brabant G. 1992 The pulsatile GH secretion in acromegaly: hypothalamic or pituary origin? Clin Endocrinol (Oxf). 37:233-239.
21. Romijn JA, Adriaanse R, Brabant G, Prank K, Endert E, Wiersinga WM. 1990 Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude. J Clin Endocrinol Metab. 70:1631-1636.
22. Hindmarsch PC, Mattews DR, Brain C, Pringle PJ, Brook CGD. 1990 The application of deconvolution analysis to elucidate the pulsatile nature of growth hormone secretion using a variable half-life of growth hormone. Clin Endocrinol (Oxf). 32:739-747.
23. Winer LM, Shaw MA, Bauman G. 1990 Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab. 70:1678-1686.
24. Hommes MJ, Romijn JA, Endert E, Eeftinck Schattenkerk JK, Sauerwein HP. 1991 Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism. 40:631-656.
25. Heyligenberg R, Romijn J, Hommes MJT, Endert E, Schattenkerk JKME, Sauerwein HP. 1993 Non-insulin-mediated glucose uptake in human immunodeficiency virus-infected men. Clin Sci. 84:209-216.
26. Merriam GR, Wachter KW. 1984 Measurement and analysis of episodic hormone secretion. In: Rodbard D, Forti G, eds. Computer in Endocrinology. New York: Raven Press; 325-346.
27. Iranmanesh A, Grisso B, Veldhuis JD. 1994 Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 78:526-535.
28. Baum HBA, Biller BMK, Katznelson L, et al. 1996 Assesment of GH secretion in men with adult-onset GH deficiency compared with that in normal men-a clinical research center study. J Clin Endocrinol Metab. 81:84-92.
29. Ross R, Miell J, Freeman E, et al. 1991 Critically ill patients have high basal growth hormone levels with attenuated oscilatory activity associated with low levels of IGF-I. Clin Endocrinol (Oxf). 35:47-45.
30. Blat C, Villaudi J, Binoux M. 1994 In vivo proteolysis of serum insulin-like growth factor binding protein-3 results in increased availability of IGF to target cells. J Clin Invest. 93:2286-2290.
31. Davies SC, Wass JA, Ross RJ, et al. 1991 The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol. 130:469-473.
32. Muller HL, Oh Y, Gargosky SE, Wilson KF, Lehrnbecher T, Rosenfeld RG. 1994 Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemia. Pediatr Res. 35:720-724.
33. Hughes CSC, Cotterill AM, Molloy AR, et al. 1992 The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol. 135:135-145.
34. Davenport ML, Isley WL, Pucilowska JB, et al. 1992 Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab. 75:590-595.
35. Holly JM, Claffey DC, Cwyfan-Hughes SC, Frost VJ, Yateman ME. 1993 Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regul. 3:88-91.
36. Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. 1995 Concentrations, release, and disposal of insulin-like growth factor(IGF)-binding proteins (IGFBP), IGF-I, and growth hormone indifferent vascular beds in patients with cirrhosis. J Clin Endocrinol Metab. 80:1148-1157.
37. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC, Rosenfeld RG. 1992 Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology 131:3051-3060.
38. Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med. 333:83-88.